Bumble is sponsoring 50 collegiate women athletes in honor of this week’s 50th Anniversary of Title IX. Photo by Kristen Kilpatrick

Bumble is causing a buzz once again, this time for collegiate women athletes. Founded by recent Texas Business Hall of Fame inductee Whitney Wolfe Herd, the Austin-based and female-first dating and social networking app this week announced a new sponsorship for 50 collegiate women athletes with NIL (name, image, and likeness) deals in honor of the 50th anniversary of Title IX.

Established in 1972, the federal law prohibits sex-based discrimination in any school or other education program or activity that receives federal money. According to the Women’s Sports Foundation, the number of women in collegiate athletics has increased significantly since Title IX, from 15 percent to 44 percent.

That said, equity continues to lag in many ways, specifically for BIPOC women who make up only 14 percent of college athletes. The findings also share that men have approximately 60,000 more collegiate sports opportunities than women, despite the fact that women make up a larger portion of the collegiate population.

With this in mind, Bumble’s new sponsorship seeks to support “a wealth of overlooked women athletes around the country,” according to the beehive’s official 50for50 program page.

“We're embarking on a yearlong sponsorship of 50 remarkable women, with equal pay amounts across all 50 NIL (name, image, and likeness) contracts,” says the website. “The inaugural class of athletes are a small representation of the talented women around the country who diligently — and often without recognition — put in the work on a daily basis.”

To celebrate the launch of the program, Bumble partnered with motion graphic artist Marlene “Motion Mami” Marmolejos to create a custom video and digital trading cards that each athlete will post on their personal social media announcing their sponsorship.

“These sponsorships are an exciting step in empowering and spotlighting a diverse range of some of the most remarkable collegiate women athletes from across the country. Athletes who work just as hard as their male counterparts, and should be seen and heard,” says Christina Hardy, Bumble’s director of talent and influencer, in a separate release. “In honor of the 50th anniversary of Title IX, we are so proud to stand alongside these women and are looking forward to celebrating their many achievements throughout the year.”

“Partnering with Bumble and announcing this campaign on the anniversary of Title IX is very special,” said Alexis Ellis, a track and field athlete. “I am grateful for the progress that has been made for women in sports, and am proud to be part of Bumble’s ’50for50’ to help continue moving the needle and striving for more. I look forward to standing alongside so many incredible athletes for this campaign throughout the year.”

“I am so grateful to team up with Bumble and stand alongside these incredible athletes on this monumental anniversary,” said Haleigh Bryant a gymnast. “Many women continue to be overlooked in the world of sports, and I am excited to be part of something that celebrates, and shines a light on, the hard work, tenacity, and accomplishments of so many great athletes.”

Last year, the NCAA announced an interim policy that all current and incoming student athletes could profit off their name, image, and likeness, according to the law of the state where the school is located, for the first time in collegiate history.

The 50for50 initiative adds to Bumble’s previous multi-year investments in sports. In 2019, Bumble also launched a multi-year partnership with global esports organization Gen.G to create Team Bumble, the all-women professional esports team.

To see the 50for50 athletes, visit the official landing page.

------

This article originally ran on CultureMap.

Whitney Wolfe Herd might be joining Austin's exclusive billionaires club. Photo by Kristen Kilpatrick

Texas entrepreneur might join exclusive list of local billionaires after buzzy deal

queen bee

An Texas tech entrepreneur soon might join the city's exclusive billionaires' club.

Whitney Wolfe Herd, founder and CEO of Austin-based dating-app provider Bumble, could move from millionaire to billionaire status if, according to reports, her Austin-based company goes public. The Bloomberg news service reported September 1 that Bumble is preparing an initial public offering, or IPO, of its stock. The IPO could value Bumble at $6 billion to $8 billion, according to Bloomberg.

In November, private equity giant Blackstone Group Inc. bought a majority stake in Bumble. At the time, Herd's Bumble business partner, Andrey Andreev, sold all of his shares in the company to Blackstone. But the Wall Street Journal reported that Herd retained the "vast majority" of her Bumble holdings. In its announcement of the deal, Blackstone said Bumble (then known as MagicLab) was valued at $3 billion.

It's not known how much of a stake in Bumble that Herd still owns; in 2017, Forbes reported she controlled 20 percent of the company's stock. If that's still the case and Bumble's value shoots to $6 billion to $8 billion with the IPO, Herd might wind up sitting on a fortune — at least on paper — in the range of $1.2 billion to $1.6 billion. Keep in mind, though, that this is a rough estimate, given the lack of clarity surrounding Herd's ownership stake.

In 2019, Forbes estimated Herd's net worth at $290 million. Before Herd established the women-centric Bumble app in 2014, the Southern Methodist University alum co-founded the Tinder dating app.

If the Bumble IPO materializes and Herd's net worth soars above $1 billion, she'd become Austin's eighth billionaire — and its second female billionaire, according to Forbes.

Last year, Herd told Inc. that she wants Bumble to be prove that a company "can still drive massive profit and be a good business model while pushing the needle on safety and privacy for users."

If Herd does soar to the billionaire stratosphere, she'll be in good company here. Tech mogul Michael Dell leads Austin's billionaire crew, followed by private equity king Robert Smith, vodka guru Tito Beveridge, hair care and tequila magnate John Paul DeJoria, tech titan Thai Lee, software baron Joe Liemandt, and private equity tycoon Brian Sheth. Lee is currently only woman in the bunch.

------

This article originally ran on CultureMap.

BumbleSpot launched in Houston at all three Nourish Juice Bar locations. Courtesy of Nourish

Texas-based Bumble launches Houston meet-up hubs for safe and productive interactions

Digital turned reality

Turning digital connections into real-life associations can be a little nerve wracking, no matter the context. Austin-based Bumble, a dating app that's expanded to become a networking resource, is trying to make that first face-to-face meeting a little safer and smoother.

"The idea for BumbleSpot is to create a network of physical locations across the US and Canada that support our mission to end misogyny and empower women in their relationships across all aspects of life," Andee Olson, director of partnerships at Bumble, says in a press release.

Over 80 BumbleSpots have been named — with more promised to announce over the next year. While Houston wasn't among the roll-out cities, it officially has three BumbleSpots to choose from, as all three Nourish Juice Bar locations have signed on as partners.

Jessica Huffman opened the first Nourish Juice Bar in the summer of 2015 in Montrose, and her Rice Village and Heights locations followed suit. She says when Bumble reached out to her, she jumped onboard since she has mutual friends with Bumble's founder and CEO, Whitney Wolfe Herd.

To be a BumbleSpot, the establishment must agree to uphold the mission and values of Bumble, which prioritizes safety, kindness, respect, equality, accountability, and growth, according to a Bumble spokesperson.

Huffman says Nourish is perfect for Bumble with its focus on healthy foods and a friendly environment.

"When you're in Nourish, you're probably going to see me or my brother or one of our employees who's worked there for a while," Huffman says. "We talk to everyone all the time and always try to make people feel comfortable."

A spokesperson says more Houston partners are coming, as local business have expressed interest following the launch of BumbleSpot.

Bumble premiered in 2014 as a female-first dating app, and moved its headquarters to Austin in 2017. In March of 2016, it launched BumbleBFF focused on creating friendships. Then, just a few months later, it launched BumbleBizz focusing on making business connections.

In August, the company launched Bumble Fund — an early-stage investment fund focused on female-led companies. The fund's first five benefactors were named as BeautyCon, Cleo Capital, Female Founders Fund, Mahmee, and Sofia Los Angeles.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.